Breaking News

31 December 2009
Quality of life in chronic pruritus measured by the ITCHYQoL
30 December 2009
Patients with severe psoriasis with no history of cardiovascular risk are at increased risk of cardiovascular mortality
29 December 2009
A controlled trial of topical tacrolimus for the treatment of pruritus in atopic dermatitis patients
28 December 2009
Effect of nalfurafine in severe itch in hemodialysis patients: A phase III, randomized, double-blind, placebo-controlled study
24 December 2009
Pharmacology of nalfurafine: A novel kappa-opioid receptor agonist
23 December 2009
Serum levels of thymus and activation-regulated chemokine CCL17 in pediatric atopic dermatitis
22 December 2009
Guidelines for biologic interventions for psoriasis, 2009
21 December 2009
Psoriasis and risk of incident cancer: An observational study
18 December 2009
Inverse relation between contact allergy and psoriasis: Results from a patient- and population-based study
17 December 2009
Itch brain activity in atopic dermatitis: Association with disease intensity and severity
16 December 2009
Educational multidisciplinary training programs for patients with chronic psoriasis
15 December 2009
Predicting risk for infantile atopic dermatitis by genetic and environmental factors
14 December 2009
Circulating regulatory T cells upregulated by biological therapies and correlate with clinical response in psoriasis
11 December 2009
Measuring patient-relevant benefits in pruritus treatment: The development and validation of a specific outcomes tool
12 October 2009
Excessive body-weight and smoking increase the risk of onset of plaque-psoriasis
12 July 2009
A 12-week controlled evaluation of oral psoralen plus ultraviolet A for treatment of plaque-type psoriasis
12 January 2009
Once-weekly etanercept improves patient-reported outcomes in patients with mild-moderate psoriasis